Cochrane · systematic review · CD004679

Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients

Campbell, D, Mudge, DW, Craig, JC, et al. · Cochrane Database of Systematic Reviews · 2017 · Cochrane Library

Kidney and TransplantAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
10
current version
GRADE rated
10
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 10 · 100%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Oral or topical or intraperitoneal antibiotics versus placebo/no treatment for preventing peritonitis in peritoneal dialysis patients

Population: patients with CKD on peritoneal dialysis
3 questions
OutcomeEffectEvidenceStatus / GRADE
Peritonitis (number of patients with one or more episodes)
Oral or topical or intraperitoneal antibiotics vs placebo/no treatment
RR 0.82 [0.57, 1.19]5 studies · 395 participantsLow
Downgraded: risk of bias, imprecision
Exit‐site/tunnel infection (number of patients with one or more episodes)
Oral or topical or intraperitoneal antibiotics vs placebo/no treatment
RR 0.45 [0.19, 1.04]3 studies · 191 participantsLow
Downgraded: imprecision
Catheter removal or replacement (number of patients)
Oral or topical or intraperitoneal antibiotics vs placebo/no treatment
RR 0.82 [0.46, 1.46]5 studies · 395 participantsLow
Downgraded: risk of bias, imprecision

Nasal antibiotics versus placebo/no treatment for preventing peritonitis in peritoneal dialysis patients

Population: patients with CKD on peritoneal dialysis
3 questions
OutcomeEffectEvidenceStatus / GRADE
Peritonitis (number of patients with one or more episodes)
Nasal antibiotics vs placebo/no treatment
RR 0.94 [0.67, 1.31]3 studies · 338 participantsLow
Downgraded: risk of bias, imprecision
Exit‐site/ tunnel infection (number of patients with one or more episodes)
Nasal antibiotics vs placebo/no treatment
RR 1.34 [0.62, 2.87]3 studies · 338 participantsLow
Downgraded: risk of bias, imprecision
Catheter removal or replacement (number of patients)
Nasal antibiotics vs placebo/no treatment
RR 0.92 [0.48, 1.78]2 studies · 289 participantsLow
Downgraded: risk of bias, imprecision

Topical disinfectants versus standard care or other active treatment (antibiotic or other disinfectant) for preventing peritonitis in peritoneal dialysis patients

Population: patients with CKD on peritoneal dialysis
3 questions
OutcomeEffectEvidenceStatus / GRADE
Peritonitis (number of patients with one or more episodes)
Topical disinfectants vs standard care or other active treatment (antibiotic or other disinfectant)
RR 0.83 [0.65, 1.06]6 studies · 853 participantsLow
Downgraded: risk of bias, imprecision
Exit‐site/tunnel infection (number of patients with one or more episodes)
Topical disinfectants vs standard care or other active treatment (antibiotic or other disinfectant)
RR 0.97 [0.74, 1.27]7 studies · 913 participantsLow
Downgraded: risk of bias, imprecision
Catheter removal or replacement (number of patients)
Topical disinfectants vs standard care or other active treatment (antibiotic or other disinfectant)
RR 0.89 [0.57, 1.38]6 studies · 792 participantsLow
Downgraded: risk of bias, imprecision

Antifungal versus placebo/no treatment for preventing peritonitis in peritoneal dialysis patients

Population: patients with CKD on peritoneal dialysis
1 question
OutcomeEffectEvidenceStatus / GRADE
Fungal peritonitis (number of patients with one or more episodes)
Antifungal vs placebo/no treatment
RR 0.28 [0.12, 0.63]2 studies · 817 participantsLow
Downgraded: risk of bias, imprecision